Antibodies Contract Manufacturing Market is expected to reach USD 35.9 billion by 2030

 Antibodies Contract Manufacturing Industry Overview

The global antibodies contract manufacturing market size was valued at USD 12.0 billion in 2021 and is anticipated to expand at a compound annual growth rate (CAGR) of 13.1% during the forecast period.

The rising emphasis of biopharmaceutical & biotechnology companies on the production of antibody therapeutics is the primary factor driving the growth. These therapeutics are extremely effective in the treatment of cancer, rheumatoid arthritis, and other chronic diseases. Consequently, there is a surge in demand for the production of therapeutic antibodies, leading to the growth of the market. Moreover, monoclonal antibody therapy is used as a treatment for COVID-19, leading to an increase in the demand for antibody production. The ongoing COVID-19 pandemic has positively impacted the market.

Gather more insights about the market drivers, restrains and growth of the Global Antibodies Contract Manufacturing Market

 As the development of mRNA vaccines and subsequent manufacturing at a global scale to respond to the COVID-19 pandemic represents a leap forward in antibody production. Currently, there are around 220 mRNA candidates in development and nucleotide-based therapies and vaccines are expected to grow at a higher growth rate. The pandemic has focused CDMO activity on rapid scale-up of production for commercial supply, but the demand for outsourced early phase development services and technology is growing in line with this new generation of molecules.

Many pharmaceutical and biotechnology businesses have increased their R&D efforts to create biologics, such as monoclonal antibodies, as these are becoming more popular as a select therapy for various lung indications, including lung cancer, asthma, and lung infections. Thus, focusing on R&D is a critical strategy for the company's long-term success.

Several pharmaceutical and biotechnology businesses are forming strategic alliances and collaborations in order to obtain market leadership. Also, major players are expanding their global footprint; for example, in January 2022, Fujifilm Diosynth Biotechnologies announced the acquisition of Atara Biotherapeutics, Inc., a company involved in cell therapy manufacturing, thus boosting the product portfolio for advanced therapies.

Biopharmaceutical manufacturing is recognized as a leading sector in terms of growth potential. Many healthcare entities believe that this sector would be one of the top 10 revenue generators in the coming years. Moreover, the market players are making continuous efforts for the development of this sector to meet the increasing demand for bio-based pharmaceuticals, which in turn, is anticipated to result in a surge of CMOs for biopharmaceutical production. This healthy growth of biopharmaceuticals has resulted in the development of a large product pipeline.

Understanding the cost-effectiveness associated with contract manufacturing, many firms have begun to outsource parts of their biopharmaceutical manufacturing to contract manufacturers. There are many biopharmaceutical products, including recombinant proteins, monoclonal antibodies, and engineered antibody-like biomolecules approved by the U.S. FDA. The number of approvals increased during the pandemic when the U.S. FDA gave Emergency Use

Browse through Grand View Research's Medical Devices Industry Research Reports

  • Intubation Tubes Market: The global intubation tubes market size was estimated at USD 2.6 billion in 2022 and is expected to witness a compound annual growth rate (CAGR) of 6.7% from 2023 to 2030.
  • Dental 3D Printing Market: The global dental 3D printing market size was valued at USD 2.5 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 26.1% from 2023 to 2030. 

Key Companies Profile

Some of the prominent players in the global antibody contract manufacturing market include:

  • Lonza
  • Samsung Biologics
  • WuXi Biologics.
  • Charles River Laboratories
  • FUJIFILM Holdings Corporation
  • Boehringer Ingelheim Biopharmaceuticals GmbH.
  • AGC Biologics
  • Cytovance Biologics, Inc.
  • EMERGENT
  • Thermo Fisher Scientific
  • Labcorp Drug Development
  • Catalent, Inc.

Order a free sample PDF of Antibodies Contract Manufacturing Market Intelligence Study, published by Grand View Research.

 

 

Comments

Post a Comment

Popular posts from this blog

Global Potash Market: Trends, Growth & Forecast 2023-2032

T he global  potash market  size is expected to reach USD 93.50 billion by 2032, growing at a CAGR of 4.9% from 2023 to 2032, according to a new study by Grand View Research, Inc. This is attributed to the increasing demand for food and efficient usage of agricultural land. As consumers seek healthier options, there has been a surge in demand for high-value crops like fruits, vegetables, and specialty crops, boosting the demand for potash. Furthermore, the adoption of precision agriculture techniques has become increasingly prevalent in recent years. Precision agriculture involves using advanced technologies and data-driven approaches, such as soil testing and targeted nutrient management, to make informed decisions about fertilizer application.   Farmers are embracing precise and site-specific methods for applying fertilizers, based on field variability and crop requirements. This trend makes way for optimized resource utilization, improved crop performance, and enhanced...
Read more

Smart Ticketing Market Report: Emerging Technologies & Market Opportunities

  The global smart ticketing market size is expected to reach USD 31.65 billion by 2030, growing at a CAGR of 15.5% from 2023 to 2030, according to a new report by Grand View Research, Inc. With the widespread adoption of smartphones, mobile ticketing channels have gained traction, allowing users to purchase, store, and validate tickets directly on their mobile devices, eliminating the need for physical cards or paper tickets. The convenience and ease of use offered by mobile ticketing have contributed to the growth of the market. Smart ticketing systems generate vast amounts of data on passenger journeys, travel patterns, and ticket usage.   Operators leverage this data to gain valuable insights, optimize operations, and improve the overall passenger experience. Data analytics techniques, such as predictive modeling and real-time monitoring, are being applied to enhance efficiency, manage capacity, and offer personalized services, which bode well for smart ticketing...
Read more

Boosting Crop Yields: India Foliar Fertilizer Market Trends & Forecasts

  The  India foliar fertilizer market  size is expected to reach USD 4.9 billion by 2030, expanding at a CAGR of 11.3% during the forecast period, as per a new report by Grand View Research, Inc. The industry growth is majorly driven by surged demand for food due to increasing population coupled with supportive government initiatives and decreasing arable land in the country.   There has been a significant increase in the global prices of fertilizers and foliar fertilizers. As such, farmers falling into small- and marginal-income categories cannot afford to buy fertilizers resulting in reduced agricultural yields. This has led the Government of India to take initiatives to provide fertilizer subsidies to farmers in the country to make them affordable at subsidized prices. For instance, the Government of India announced a subsidy scheme related to fertilizers worth USD 27 billion in 2022 to ensure that fertilizers are affordable for every farmer in the country. Thus, ...
Read more